Effects of Clostridium difficile Toxin A on the proteome of colonocytes studied by differential 2D electrophoresis

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 469-479

  Zeiser, Johannes J ^a   Klodmann, Jennifer ^b   Braun, Hans Peter ^b   Gerhard, Ralf ^a   Just, Ingo ^a   Pich, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

2D DIGE; Caco 2; Clostridium difficile; Proteome map; Toxin A

Indexed keywords

BETA ACTIN; CLOSTRIDIUM DIFFICILE TOXIN A; EZRIN; GLUCOSYLTRANSFERASE; UBIQUITIN;

ARTICLE; CELLULAR STRESS RESPONSE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; INTESTINE CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

BACTERIAL TOXINS; CACO-2 CELLS; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; GLUCOSYLTRANSFERASES; HUMANS; PROTEOME; TANDEM MASS SPECTROMETRY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

CLOSTRIDIUM DIFFICILE;

EID: 82355173202     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.012     Document Type: Article

References (50)

1. Kelly C.P., LaMont J.T. Clostridium difficile-more difficult than ever. N Engl J Med 2008, 359:1932-1940.
2. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
3. Just I., Gerhard R. Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 2004, 152:23-47.
4. Papatheodorou P., Zamboglou C., Genisyuerek S., Guttenberg G., Aktories K. Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS One 2010, 10.1371/journal.pone.0010673.
5. Egerer M., Giesemann T., Jank T., Satchell K.J., Aktories K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J Biol Chem 2007, 282:25314-25321.
6. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 2007, 446:415-419.
7. Genth H., Dreger S.C., Huelsenbeck J., Just I. Clostridium difficile toxins: More than mere inhibitors of Rho proteins. Int J Biochem Cell Biol 2008, 40:592-597.
8. Huelsenbeck J., Dreger S., Gerhard R., Barth H., Just I., Genth H. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun 2006, 75(2):801-809.
9. Nottrott S., Schoentaube J., Genth H., Just I., Gerhard R. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases. Apoptosis 2007, 12(8):1443-1453.
10. Teichert M., Tatge H., Schoentaube J., Just I., Gerhard R. Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effects. Infect Immun 2006, 74(10):6006-6010.
11. Chen M.L., Pothoulakis C., LaMont J.T. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem 2002, 277:4247-4254.
12. He D., Sougioultzis S., Hagen S., Liu J., Keates S., Keates A.C., et al. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 2002, 122:1048-1057.
13. Kim H., Kokkotou E., Na X., Rhee S.H., Moyer M.P., Pothoulakis C., et al. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 2005, 129:1875-1888.
14. He D., Hagen S.J., Pothoulakis C., Chen M., Medina N.D., Warny M., et al. Clostridium difficile toxin A causes early damage to mitochondria in cultured cells. Gastroenterology 2000, 119(1):139-150.
15. Matarrese P., Falzano L., Fabbri A., Gambardella L., Frank C., Geny B., et al. Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem 2007, 282:9029-9041.
16. Burger S., Tatge H., Hofmann F., Genth H., Just I., Gerhard R. Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochem Biophys Res Commun 2003, 307:584-588.
17. Drudy D., Harnedy N., Fanning S., Hannan M., Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 2007, 28(8):932-940.
18. Lyras D., O'Connor J.R., Howarth P.M., Sambol S.P., Carter G.P., Phumoonna T., et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458(7242):1176-1179.
19. Kuehne S.A., Cartman S.T., Heap J.T., Kelly M.L., Cockayne A., Minton N.P. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467(7316):711-713.
20. Mitchell T.J., Ketley J.M., Haslam S.C., Stephen J., Burdon D.W., Candy D.C., et al. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986, 27(1):78-85.
21. Mitchell T.J., Ketley J.M., Burdon D.W., Candy D.C., Stephen J. Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin. J Med Microbiol 1987, 23(3):211-219.
22. Lyerly D.M., Saum K.E., MacDonald D.K., Wilkins T.D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985, 47:349-352.
23. Gerhard R., Tatge H., Genth H., Thum T., Borlak J., Fritz G., et al. Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J Biol Chem 2005, 280(2):1499-1505.
24. Gerhard R., Nottrott S., Schoentaube J., Tatge H., Olling A., Just I. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J Med Microbiol 2008, 57:765-770.
25. Bradford M.M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
26. Genth H., Huelsenbeck J., Hartmann B., Hofmann F., Just I., Gerhard R. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett 2006, 580:3565-3569.
27. Alban A., David S.O., Bjorkesten L., Andersson C., Sloge E., Lewis S., et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3(1):36-44.
28. Matarrese P., Falzano L., Fabbri A., Gambardella L., Frank C., Geny B., et al. Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem 2007, 282:9029-9041.
29. Ong S.E., Mann M. Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol Biol 2007, 359:37-52.
30. Cox J., Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem 2011, 80:273-299.
31. Sato N., Funayama N., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992, 103:131-143.
32. Tsukita S., Yonemura S., Tsukita S. ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem Sci 1997, 22:53-58.
33. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998, 140:647-657.
34. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., et al. Regulation mechanism of ERM (Ezrin/Radixin/Moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996, 135(1):37-51.
35. Zhu L., Hatakeyama J., Chen C., Shastri A., Poon K., Forte J.G. Comparative study of ezrin phosphorylation among different tissues: more is good; too much is bad. Am J Physiol Cell Physiol 2008, 295(1):192-202.
36. Fukata Y., Itoh T.J., Kimura T., Ménager C., Nishimura T., Shiromizu T., et al. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 2002, 4(8):583-591.
37. Fiorentini C., Arancia G., Paradisi S., Donelli G., Giuliano M., Piemonte F., et al. Effects of Clostridium difficile toxins A and B on cytoskeleton organization in HEp-2 cells: a comparative morphological study. Toxicon 1989, 27(11):1209-1218.
38. Fiorentini C., Malorni W., Paradisi S., Giuliano M., Mastrantonio P., Donelli G. Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun 1990, 58(7):2329-2336.
39. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005, 23:94-101.
40. Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., et al. Phosphoproteome of resting human platelets. J Proteome Res 2008, 7:526-534.
41. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4(9):1265-1272.
42. Glatz J.F.C., Börchers T., Spener F., van der Vusse G.J. Fatty acids in cell signalling: modulation by lipid binding proteins. Prostaglandins Leukot Essent Fatty Acids 1995, 52:121-127.
43. Roth K.A., Hertz J.M., Gordon J.I. Mapping enteroendocrine cell populations in transgenic mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal tract. J Cell Biol 1990, 110:1791-1801.
44. Sweetser D.A., Birkenmeier E.H., Hoppe P.C., McKeel D.W., Gordon J.I. Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev 1988, 2:1318-1332.
45. Rajaraman G., Wang G.Q., Yan J., Jiang P., Gong Y., Burczynski F.J. Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment. Mol Cell Biochem 2007, 295(1-2):27-34.
46. Holland L.Z. Developmental biology: a chordate with a difference. Nature 2007, 447:153-155.
47. Jiménez-Lara A.M., Aranda A., Gronemeyer H. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms. Mol Cancer 2010, 9:15.
48. Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Kéri G., et al. Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 2009, 8(7):1751-1764.
49. Duncan R., Bazar L., Michelotti G., Tomonaga T., Krutzsch H., Avigan M., et al. A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 1994, 8(4):465-480.
50. Gearhart J., Pashos E.E., Prasad M.K. Pluripotency redux-advances in stem-cell research. N Engl J Med 2007, 357(15):1469-1472.